Eli Lilly and Company (LLY) CAPEX/Revenue US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
CAPEX/Revenue, % | 6.06% | 8.27% | 6.61% | 8.70% | 21.7% | 20.8% | |||
Changes by years, y/y, % | -8pp | +2pp | -2pp | +2pp | +13pp | +9.1% |
Eli Lilly and Company. CAPEX/Revenue, %
Eli Lilly and Company. CAPEX/Revenue, changes, pp
Eli Lilly and Company (LLY) CAPEX/Revenue US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
CAPEX/Revenue, % | 13.0% | 10.1% | 42.1% | 17.7% | 11.2% | 20.8% | ||
Changes by years, y/y, % | +2pp | +3pp | +33pp | +10pp | -2pp | |||
Changes by quarters, q/q, % | +5pp | -3pp | +32pp | -24pp | -6pp |